Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Aledort

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|January 19, 1978
Inhibition of ejaculation due to epsilon aminocaproic acidB E Evans, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Editorial ForewordL M Aledort, C R Hay
Transfusion|June 1, 1994
Considerations governing factor IX product choice in hemophilia BG L Bray, L M Aledort
The American Journal of Cardiology|November 4, 1976
Human model for the study of abnormal platelet function in atherosclerotic heart diseaseJ A Ambrose, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2007
Coagulation deficiencies: a look to the futureC A Lee, L M Aledort
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
Prophylaxis and continuous infusion for hemophilia: can we afford it?L M Aledort, R L Bohn
Drugs|April 1, 1993
Congenital bleeding disorders. Rational treatment optionsS V Seremetis, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 15, 2007
Prophylaxis in the haemophilia population-optimizing therapyM D Carcao, L M Aledort,
Progress in Hematology|January 1, 1981
Hemophilia treatment: its relationship to blood productsL M Aledort, S H Goodnight
The Journal of Biological Chemistry|January 25, 1971
Colchicine-binding protein from human platelets and its effect on muscle myosin and platelet myosin-like thrombosthenin-ME Puszkin, S Puszkin, L M Aledort
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|January 19, 1978
Inhibition of ejaculation due to epsilon aminocaproic acidB E Evans, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Editorial ForewordL M Aledort, C R Hay
Transfusion|June 1, 1994
Considerations governing factor IX product choice in hemophilia BG L Bray, L M Aledort
The American Journal of Cardiology|November 4, 1976
Human model for the study of abnormal platelet function in atherosclerotic heart diseaseJ A Ambrose, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2007
Coagulation deficiencies: a look to the futureC A Lee, L M Aledort
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
Prophylaxis and continuous infusion for hemophilia: can we afford it?L M Aledort, R L Bohn
Drugs|April 1, 1993
Congenital bleeding disorders. Rational treatment optionsS V Seremetis, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 15, 2007
Prophylaxis in the haemophilia population-optimizing therapyM D Carcao, L M Aledort,
Progress in Hematology|January 1, 1981
Hemophilia treatment: its relationship to blood productsL M Aledort, S H Goodnight
The Journal of Biological Chemistry|January 25, 1971
Colchicine-binding protein from human platelets and its effect on muscle myosin and platelet myosin-like thrombosthenin-ME Puszkin, S Puszkin, L M Aledort
Pageof 19